hoffmann6383 Profile Banner
Hoffmann Profile
Hoffmann

@hoffmann6383

Followers
3K
Following
20K
Media
771
Statuses
4K

Attorney. Investor. Tweets are my own opinion and DO NOT represent investment, legal or medical advice.

USA
Joined May 2022
Don't wanna be here? Send us removal request.
@hoffmann6383
Hoffmann
2 years
I wrote an article about $NWBO: https://t.co/sOhaEsuQJU I encourage everyone to read it. What is happening with NWBO is astounding and our persistent retail investor has hung on through it all. I believe we will all be much better off when this story comes to its' ending.
Tweet card summary image
reddit.com
Explore this post and more from the NWBO community
46
142
425
@hoffmann6383
Hoffmann
1 day
📰Today's 8K $NWBO ➡️10-31-25 Form 8K https://t.co/SMtVEM9zIE "On October 27, 2025, Northwest Biotherapeutics, Inc. (the “Company”) entered into a Commercial Loan Agreement and Note (collectively, the “Loan Agreement”) with Streeterville Capital, LLC (the “Holder”) in the
8
19
138
@hoffmann6383
Hoffmann
8 days
As a follow up, $NWBO has now closed the Advent acquisition https://t.co/4SHJDop4Ox Since we're in Q4 we likely won't see Advent's Financials until the 10K. As I stated prior, this oozes confidence that NWBO’s #DCVax-L will ultimately be approved as LP/Toucan would have had
Tweet card summary image
prnewswire.com
/PRNewswire/ -- Northwest Biotherapeutics, Inc. (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax® personalized immune...
4
15
114
@hoffmann6383
Hoffmann
15 days
Defendant MMs win this round. $NWBO must disclose the requested information. Also, a nice note from Magistrate Stein on the Order regarding Les Goldman.
4
2
57
@hoffmann6383
Hoffmann
15 days
➡️NWBO's non-testifying expert identified⬅️ $NWBO's non-testifying expert: Joshua Mitts The Case: Northwest Biotherapeutics, Inc v. Canaccord Genuity LLC, 1:22-cv-10185, (S.D.N.Y.) On October 13th we saw Defendant Market Makers request the Court enter an order to identify "all
6
18
114
@hoffmann6383
Hoffmann
18 days
Where did I get the number of ~23m in $NWBO stock options being returned? Take 17% of the number in the attached Image, which comes from Plaintiff's Second Amended Complaint filed publicly today.
0
0
43
@hoffmann6383
Hoffmann
18 days
⚖️NWBO Derivative Lawsuit Settled Case Name: CONF ORDER - CONS W/2022-0212-JTL AND 2022-0259-JTL - IN RE NORTHWEST BIOTHERAPEUTICS, INC. STOCKHOLDER LITIGATION ➡️What was Plaintiff claiming? From today's public filing of the Second Amended Complaint we see the Plaintiff
1
6
81
@hoffmann6383
Hoffmann
18 days
⚖️NWBO Spoofing Lawsuit Update The Case: Northwest Biotherapeutics, Inc v. Canaccord Genuity LLC, 1:22-cv-10185, (S.D.N.Y.) The Docket: https://t.co/SNKTxns1sw $NWBO is engaged in discovery with seven of the largest market makers in the world, including @citsecurities and
2
4
89
@hoffmann6383
Hoffmann
19 days
Highly doubtful any academic presentation put on an agenda months ago will have anything to do with the approval process for $NWBO's DCVax-L. Keep expectations reasonable for tomorrow. No need to create a narrative based on a misunderstanding of academic conferences that likely
7
2
100
@hoffmann6383
Hoffmann
23 days
The wildcard that has to be taken into account when looking at settlement is punitive damages, especially in $NWBO's own spoofing case, imo. Punitive damages are designed to deter and punish. You look at the size of the offender and ask what will deter this sort of future
7
20
134
@hoffmann6383
Hoffmann
23 days
⚖️UBS Securities LLC makes early attempt to settle civil spoofing case Defendant, UBS Securities LLC ("UBS"), appears concerned about what might surface in discovery and are pushing settlement discussions. The Case: Phunware, Inc. v. UBS Securities LLC, 1:23-cv-06426,
8
37
143
@hoffmann6383
Hoffmann
1 month
I think i messed up slightly on the calculations. Minus a month and it would be more accurate. Call it October 2nd or later for a decision. $NWBO Either way, point is we could still be within the statutory timeframe and a decision would be due shortly.
1
2
64
@hoffmann6383
Hoffmann
1 month
➡️Is $NWBO's DCVax-L Within the Statutory Review Period for a MAA? Short answer: Possibly. It is plausible that $NWBO's #DCVax-L application for approval with the MHRA is still within the statutory timeframe for review. Below I'll lay out a scenario that shows $NWBO could
Tweet card summary image
gov.uk
Guidance on the MHRA’s national assessment procedure for marketing authorisation applications.
8
5
89
@hoffmann6383
Hoffmann
1 month
Good stuff Thomas. Thanks for sharing. Always appreciate your inspirational story and passion when it comes to cancer research.
@ThomasOwenMcCa1
Thomas Owen McCaffrey
1 month
I had the honor of being invited to the @UCLANsgy brain tumor fundraiser. It was a very emotional & powerful day. It’s really concerning to me that the current administration dismantled a 50 year program to save millions of lives in just six months. Six months, I guess cruelty
1
4
37
@hoffmann6383
Hoffmann
1 month
$NWBO Spoofing Lawsuit - What is happening? The Case: Northwest Biotherapeutics, Inc v. Canaccord Genuity LLC, 1:22-cv-10185, (S.D.N.Y.) The Docket: https://t.co/D0tfjlyLOe Right now we are in the middle of discovery. In this post I'll go through the relevant timelines seen in
Tweet card summary image
courtlistener.com
Docket for Northwest Biotherapeutics, Inc v. Canaccord Genuity LLC, 1:22-cv-10185 — Brought to you by Free Law Project, a non-profit dedicated to creating high quality open legal information.
3
9
96
@hoffmann6383
Hoffmann
1 month
Nice to see that recognition. Thanks for sharing. Now it's time to get her contributions to the patients 😉 $NWBO
@sharpie510
rj
2 months
Dr. Linda Liau has received the J.E. Wallace Sterling Lifetime Achievement Award in Medicine from the Stanford Medicine Alumni Association in recognition of her exceptional contributions to medicine and the biosciences. 👏 $nwbo #dcvax #glioblastoma #gbm https://t.co/hXs0jwmsX2
2
4
84
@hoffmann6383
Hoffmann
2 months
Liehub is relentless. My last post on this topic for the day, I promise! That place doesn't deserve any additional attention. Once it was shown that Dr. Prasad's comments in AF's article were misquoted and/or taken completely out of context now we have the usual nefarious
1
1
26
@hoffmann6383
Hoffmann
2 months
And now the false narrative is amplified by the usual accounts on liehub. See Image 1. Same playbook they've been using for years to try to scare unknowing retail investors. And while we have posters like Exwannabe that has spent nearly every day for a decade posting negative
3
1
49
@hoffmann6383
Hoffmann
2 months
Literally making up a quote that is attributed to Dr. Prasad that (surprise surprise) paints $NWBO in a negative light. A typical Wednesday on liehub.
3
3
62